Home>

Products

Submit Request Quote
 * Denotes Required Field.
Name:
 *
Company Name:
Phone:
Email:
 *
Message:
Request Quote
 
Out Of Stock image

Is currently out of stock, however if you enter your email address we will notify you when it comes back into stock!

Continue shopping Get Notified

Anti-rhesus thymocyte [rhATG] - (all lots)

Anti-rhesus thymocyte [rhATG] - (all lots)
Product Type: Therapeutics (In Vivo)
Format: Anti-rhesus thymocyte, rhATG, polyclonal rabbit IgG
Clone ID: [rhATG]
RRID: AB_2716327
Common Names: Anti-rhesus thymocyte [rhATG] - Retired Lots 1-6 | Anti-rhesus Thymocyte Globulin | PR-1077 | ATG |rhATG1 [AB051316] | rhATG2 [WF122916] | rhATG3 [WF021818] | rhATG5 [WF101518] | rhATG6 [WF071819] | rhATG7 [BL121019]
Target: rhesus thymocytes
Reactivity: Rhesus Macaque (Macaca mulatta)
Applications: in vivo; depletion
Description:

Rhesus ATG was discontinued. Please find our announcement here.

 

rhATG: Purified rabbit IgG from serum of rabbits immunized with rhesus thymocytes.
Retired Lots (no longer available).

 

Legacy lots

rhATG1 [AB051316] – 2015
• (10 animals) 50mil thymocytes resuspended in PBS, dose S.C. on days 0, 21, 36.
• Harvest on day 50.

rhATG2 [WF122916] – 2016
• (40 animals) 50mil thymocytes resuspended in PBS, dose S.C. on days 0, 21, 36.
• Harvest on day 50.

rhATG3 [WF021818] – 2017
• (100 animals) 50mil thymocytes resuspended in PBS, dose S.C. on days 0, 21, 36. • Harvest on day 50.

rhATG4 – Internal Immunization Test – Not released.
• (5 non-responders from ATG 3) 50mil thymocytes resuspended in PBS, dose S.C. on days 0, 21, 36. Five non-responding animals were moved from study ATG3 to ATG4, and immunized with rhesus thymocytes resuspended in adjuvant on days 58, 86, and 100.
• Harvest on day 114.

rhATG5 [WF101518] – Adjuvanted – 2018
• (10 animals) 50mil thymocytes resuspended in Adjuvant, dose S.C. on Day 0. 50mil thymocytes resuspended in Adjuvant, dose S.C. on Day 14 and 28.
• Harvest on day 35.

rhATG6 [WF071819] – 2019
• (40 animals) 50mil thymocytes resuspended in PBS, dose S.C. on days 0, 21, 36.
• Harvest on day 50.

rhATG7 [BL121019] – 2019
• (100 animals) 50mil thymocytes resuspended in PBS, dose S.C. on days 0, 21, 36.
• Harvest on day 50.

rhATG8 [BL041021] – 2021 
• (100 animals) 50mil thymocytes resuspended in PBS, dose S.C. on days 0, 21, 36.
• Harvest on day 50.

rhATG9 [BL110121] – 2021 
• (100 animals) - Adjuvanted

rhATG10 [J4821-XL01] – 2021
• (5 animals) - Adjuvanted 

rhATG11 [J4821-XL11] – 2021
• (5 animals) - Adjuvanted and lyophilized


Rhesus ATG will be discontinued in 2022. Please find our announcement here.
Modifications: None
Restrictions: No
Sponsor: NIAID
How to cite (Methods): The Anti-rhesus thymocyte [rhATG] - (all lots) antibody was engineered and produced by the Nonhuman Primate Reagent Resource (NIH Nonhuman Primate Reagent Resource Cat#PR-0000e,RRID:AB_2716327).
How to cite (Acknowledgments): The Anti-rhesus thymocyte [rhATG] - (all lots) antibody used in this study was provided by the NIH Nonhuman Primate Reagent Resource (NIAID U24 AI126683).

Reagent cost, which is the actual cost of production, is recovered for some reagents. Please inquire if you have questions about reagent cost recovery. Purchase order or credit card is NOW REQUIRED for cost-recovered reagents.

You are not authorized to purchase this product. Please ensure you are logged into your account.

CAN'T FIND EXACTLY WHAT YOUR RESEARCH REQUIRES?

Request a Reagent:

Would you like to see an NHP-specific antibody developed through the program? Suggest a new reagent that would benefit the NHP community.

REQUEST A REAGENT

The Nonhuman Primate Reagent Resource (NHPRR) is a nonprofit laboratory established in 1999, and supported by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), and Office of Research Infrastructure Programs (ORIP).

Copyright © 2004-2024